- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: JNJ-64041575 (oral tablet formulation )
Total 2060 results
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCWithdrawn
-
Aragon Pharmaceuticals, Inc.Completed
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Janssen Research & Development, LLCTerminatedCarcinoma, Non-Small-Cell LungUnited States
-
Janssen Research & Development, LLCTerminatedRespiratory Syncytial VirusesAustralia, France, United Kingdom, Belgium, Taiwan, United States, Spain, Argentina, Mexico, Bulgaria, Malaysia, Japan, Sweden, Korea, Republic of, Canada, Netherlands, Brazil, Germany, Poland
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCTerminatedRespiratory Syncytial VirusesUnited States, Belgium, Canada, Hungary, Japan, Poland
-
Janssen Research & Development, LLCWithdrawnMetapneumovirusNetherlands, United States, France, Taiwan, Korea, Republic of, Australia, Japan, Spain, Malaysia, Russian Federation, Sweden, Poland, Bulgaria, Argentina, Brazil, Ukraine
-
Janssen Research & Development, LLCCompleted
-
Harmony Biosciences, LLCActive, not recruitingPrader-Willi SyndromeUnited States
-
Janssen Research & Development, LLCCompleted
-
Janssen-Cilag International NVCompleted
-
AstraZenecaParexelCompletedCoronary Artery Disease (CAD)United Kingdom
-
AstraZenecaCompletedHealthy Volunteers | Pharmacologic ActionUnited States
-
Janssen Research & Development, LLCCompleted
-
Fulcrum TherapeuticsCompletedHealthy Adult SubjectsUnited States
-
PfizerCompleted
-
Boehringer IngelheimCompleted
-
Rigshospitalet, DenmarkCompletedHyponatremia | Metabolic Bone DiseaseDenmark
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus | Infections, Human Immunodeficiency Virus and HerpesviridaeUnited States
-
Paratek Pharmaceuticals IncActive, not recruitingMycobacterium Infections, Nontuberculous | Nontuberculous Mycobacterial Lung Disease | Mycobacterium Abscessus Infection | Nontuberculous Mycobacterial Pulmonary InfectionUnited States
-
Janssen R&D IrelandCompleted
-
Aragon Pharmaceuticals, Inc.Completed
-
Forendo Pharma LtdRichmond Pharmacology LimitedCompletedRelative BioavailabilityUnited Kingdom
-
Janssen Sciences Ireland UCCompleted
-
Eli Lilly and CompanyCompleted
-
Janssen Research & Development, LLCTerminated
-
EstetraICON Clinical ResearchCompletedVasomotor Symptoms | Menopausal SymptomsUnited States, Canada
-
CSPC Ouyi Pharmaceutical Co., Ltd.CompletedHealthy ParticipantsChina
-
VaxartCompletedNorovirus InfectionUnited States
-
Cogent Biosciences, Inc.RecruitingMastocytosis | Mastocytosis, Systemic | SSM | Mastocytosis, IndolentUnited States, Italy, Canada, Australia, Spain, Switzerland, Norway, United Kingdom, Belgium, Poland, Netherlands, Germany, France, Czechia, Greece, Ireland
-
PfizerArvinas Estrogen Receptor, Inc.Recruiting
-
EicOsis Human Health Inc.RecruitingNeuropathic Pain | Spinal Cord InjuriesUnited States
-
Fulcrum TherapeuticsTerminated
-
EicOsis Human Health Inc.CompletedHealthy AdultsUnited States
-
EicOsis Human Health Inc.RecruitingHealthy SubjectsNew Zealand
-
Harmony Biosciences, LLCActive, not recruitingMyotonic Dystrophy 1 | Excessive Daytime SleepinessUnited States, Canada
-
Syntrix Biosystems, Inc.National Institute on Drug Abuse (NIDA); DF/Net ResearchCompletedDiabetic Neuropathies | Neuropathic Pain | Pain, ChronicUnited States
-
Cara Therapeutics, Inc.CompletedChronic Kidney Diseases | PruritusUnited States
-
Cylene PharmaceuticalsUnknownBreast Cancer | Multiple Myeloma | Advanced Solid Tumors | Inflammatory Breast Cancer | Castleman's DiseaseUnited States
-
VaxartCompletedNorovirus GastroenteritisUnited States
-
PfizerRecruitingHealthy ParticipantsUnited States
-
Damanhour UniversityCompleted
-
Baylor Research InstituteNot yet recruitingBreast Cancer | Metastatic Triple-Negative Breast CarcinomaUnited States
-
Boehringer IngelheimCompleted
-
VaxartCompletedRespiratory Syncytial Virus (RSV)United States
-
Orion Corporation, Orion PharmaEndo PharmaceuticalsCompleted
-
University of California, Los AngelesRecruitingPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States